Aortech Share Discussion Threads

[davisc5] 19/2/2019 08:44

Another chunk added, had to do it in 3 transactions :o(

[blueball] 19/2/2019 08:42

60p target in sight.

[someuwin] 19/2/2019 08:17

The Chart alone suggests a move to 120 is on the cards. Just needs some news to set it in motion.

(even at 120p the valuation would still be only about £17m)


free stock charts from uk.advfn.com

[bones] 18/2/2019 20:49

Sounds fair!

[landy90] 18/2/2019 20:46

I suspect that any IP infringement would only be worth looking at once commercialised. By that time both AOR and Foldax will ne owned by someone else and it will be Baxter’s v Abbot or whatever rather than Bill v Frank.
More value in getting polymer valves into the market than frustrating launch.

[bones] 18/2/2019 20:37

Interesting Landy90. Intriguing also given that the ex-CEO of AorTech allegedly went off with some know-how. How does AOR stand on whether Foldax are transgressing AOR IP with their "bio polymer"?

[landy90] 18/2/2019 20:26

Foldax, the business AorTech were in dispute with have just announced first in man approval from the FDA for a polymer valve that looks very much like the AorTech offering.



This is very good news for AorTech and gives additional confidence that the AorTech valve should also get FDA approval to start trials.

A polymer valve going into man changes the mindset of the heart valve majors that still trade off 40 year old technology. Polymer valves are now no longer an interesting academic exercise but a serious commercial risk to their businesses.

There are 4 or 5 large valve companies, only one of them could buy Foldax… where do the rest go to for this technology?

As an interesting read through on the valuation of AorTech, Foldax raised over $10m in December to fund this trial at an estimated valuation of well over $100m.

AorTech may be little behind but in addition to the valve (patented) it has the polymer business, the patches and the grafts. All for less than 10% of the value placed on Foldax.

[cocker] 18/2/2019 20:22

Bluebell, they seem to buy one week and sell almost within a couple. Really not sure anything they say is relevant as the spread is 10% most of the time, therefore 20%+ would be needed to make it worth a punt.

[blueball] 18/2/2019 20:07

Stay long.

[langland] 18/2/2019 17:36

SV
I do keep half an eye.....I think it will get there eventually FWIW.

[turbotrader2] 18/2/2019 17:32

Coiled spring this one

[semper vigilans] 18/2/2019 17:25

Thanks Langland - this looks like it could be good.
AGL hopefully getting closer to FDA approval so I’m still in.

[langland] 18/2/2019 17:16

SV

No I am not. I think I sold the last around 70p year or 2 back. Had held from June 2009. Just got fed up with Newland's bull s... though in fairness I did make a lot out of it. Had 500k shares at one time.

Still, here's hoping with AOR. Got a decent size and am looking for £2+ around October time.

[someuwin] 18/2/2019 16:27

Chart looks good for a big rise soon.

[semper vigilans] 18/2/2019 16:19

Agree Langland - are you still in AGL?

[langland] 18/2/2019 16:16

These seem to be quite well bid at the moment. My broker had to make a few calls to get me 5 at 51.

[semper vigilans] 18/2/2019 12:13

No problem through an old fashioned broker!

[turbotrader2] 18/2/2019 10:33

What is the point??You can't even buy £500 online

[the stigologist] 15/2/2019 11:32

Chart set up looks good. Needs to take out the 200 day on Volume.

[bones] 15/2/2019 10:34

TT, do you mean the high achieved before all the donkeys walked off the beach?

[turbotrader2] 15/2/2019 10:14

Looks like we could test the recent high of this week

[netcurtains] 15/2/2019 10:05

..imagine what will happen with a good RNS release

[netcurtains] 15/2/2019 10:04

doesn't take much buying or selling to make it swing wildly

[langland] 15/2/2019 10:03

Interesting TAVI procedure performed on Hospital last night. Hopefully, this is a segment AOR are hoping to address but landy should be able to answer this?

[turbotrader2] 15/2/2019 09:35

Never can to be fair